Programmed Death Ligand-1-directed Antibody Interactions
- Name
- Programmed Death Ligand-1-directed Antibody Interactions
- Accession Number
- DBCAT004243
- Description
Not Available
- Drugs
Drug Drug Description Avelumab An anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma. Durvalumab An antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer. - Drugs & Drug Targets
Drug Target Type Avelumab Programmed cell death 1 ligand 1 target Durvalumab Programmed cell death 1 ligand 1 target Durvalumab Programmed cell death protein 1 target